GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regent Pacific Group Ltd (OTCPK:RPGLF) » Definitions » Common Stock

RPGLF (Regent Pacific Group) Common Stock : $0.23 Mil (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Regent Pacific Group Common Stock?

Regent Pacific Group's quarterly common stock declined from Jun. 2023 ($45.67 Mil) to Dec. 2023 ($0.23 Mil) but then stayed the same from Dec. 2023 ($0.23 Mil) to Jun. 2024 ($0.23 Mil).

Regent Pacific Group's annual common stock increased from Dec. 2021 ($23.99 Mil) to Dec. 2022 ($24.00 Mil) but then declined from Dec. 2022 ($24.00 Mil) to Dec. 2023 ($0.23 Mil).


Regent Pacific Group Common Stock Historical Data

The historical data trend for Regent Pacific Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regent Pacific Group Common Stock Chart

Regent Pacific Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.37 23.99 23.99 24.00 0.23

Regent Pacific Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.99 24.00 45.67 0.23 0.23

Regent Pacific Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Regent Pacific Group Business Description

Traded in Other Exchanges
Address
5 Queen's Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.

Regent Pacific Group Headlines

No Headlines